echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > FDA approves Xellia Pharmaceuticalready pre-mixed vancomycin injection

    FDA approves Xellia Pharmaceuticalready pre-mixed vancomycin injection

    • Last Update: 2020-06-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    recently, XelliaPharmaceutical(http://company(http://announced that the U.SFood andMedicines(http://Administration (
    FDA(http://) has approved the ready-to-use (RTU) premixed vancomycin injectionFebruary 2018, the FDA granted theProduct(http://Qualified Infectious Disease Products (QIDP) to theAbout Vancomycin InjectionVancomycin Injection RTU is apatented(http://formula of vancomycin, provided as a premixed solution in a single-dose flexible bag, stable for 16 months at room temperature (up to 25 degrees C)Itspackaging(http://are 100 ml, 200 ml, 300 ml, 400 ml, respectively, containing 500 mg, 1 g, 1.5 g, 2.0 g vancomycinEach 100 ml solution contains 1.8 ml of polyglycol 400, 1.36 grams N-acetyl-D-alanine, 1.26 grams of L-lysine hydrochloride in water injection waterSodium hydrochloric acid and sodium hydroxide are used to regulate acidity and alkalinityVancomycin injection is a glycopeptide antibacterial agent for adults and children (1 month and above) to treat sepsis, infectious endocarditis, skin and skin structure infections, bone infections and lower respiratory tract infectionsVancomycin injection RTU is a new vancomycin preparation, which was approved based on more than 60 non-clinical studies, including studies confirming that the new formulation will not adversely affect the efficacy of the active ingredient vancomycin
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.